Expand NUVB Menu
NUVB MENU

NUVB Latest Press Releases

-- December 6, 2025 --

Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List PRNewswire 10:40 PM

-- December 3, 2025 --

Nuvation Bio Announces Publication of Positive Phase 2 Study Results for Safusidenib for the Treatment of Grade 2 IDH1-Mutant Glioma in Neuro-Oncology Business Wire 8:00 AM

-- November 26, 2025 --

Nuvation Bio to Participate in Upcoming Investor Conferences Business Wire 4:05 PM

-- November 3, 2025 --

Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update Business Wire 4:05 PM

-- October 30, 2025 --

Nuvation Bio to Participate in Upcoming Investor Conferences Business Wire 4:05 PM

-- October 23, 2025 --

Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma Business Wire 7:30 AM

-- October 20, 2025 --

Nuvation Bio to Report Third Quarter 2025 Financial Results and Provide Business Update on November 3, 2025 Business Wire 4:05 PM

-- October 8, 2025 --

NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street PRNewswire 8:55 AM

-- September 30, 2025 --

Nuvation Bio Enrolls First Patient in TRUST-IV Phase 3 Study of IBTROZI (taletrectinib) for the Adjuvant Treatment of ROS1-Positive Early-Stage Non-Small Cell Lung Cancer Business Wire 7:30 AM

-- September 19, 2025 --

Nuvation Bio Receives Approval from Japan's Ministry of Health, Labour and Welfare for IBTROZITM for Patients with Advanced ROS1-positive Non-Small Cell Lung Cancer Business Wire 7:30 AM

-- September 7, 2025 --

Nuvation Bio Announces New Data from Pivotal Clinical Studies of IBTROZI (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at 2025 World Conference on Lung Cancer Business Wire 6:00 AM

-- August 27, 2025 --

Nuvation Bio to Participate in Upcoming Investor Conferences Business Wire 4:05 PM

-- August 7, 2025 --

Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update Business Wire 7:30 AM

-- July 24, 2025 --

Nuvation Bio to Report Second Quarter 2025 Financial Results and Provide Business Update on August 7, 2025 Business Wire 4:05 PM
Market Data Delayed 15 Minutes